% | $
Quotes you view appear here for quick access.

SIGA Technologies Inc. Message Board

golongin2008 538 posts  |  Last Activity: 6 hours ago Member since: Nov 25, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • golongin2008 golongin2008 6 hours ago Flag

    No balls no glory AK.... I buy very large positions in stocks I believe in regardless of price or hype by anyone.

    QURE....Already made a ton on it...Teens to 33's in a very short time thanks to the BMY deal....Then got out cause I felt that would be the real positive news for a time, and thankfully I was right thus far. QURE is the real deal though AK. If it was in the USA it would be double the price. Read up on it my man. $140 stocks are lower risk (BLUE) but there is already huge success built into the price. And a failed anything? Whamo....

    AKAO is simply a crap shoot.

    TGTX...I have a very postitive feeling on that one but could be wrong.

    TTPH.... In no rush to pay up frankly.

  • golongin2008 golongin2008 21 hours ago Flag

    Obviously a lage position in TGTX from low 15's.... I feel a homerun coming there frankly...

  • golongin2008 golongin2008 21 hours ago Flag

    Just bought a large position in AKAO in the 6's... Terrible management and baasically starting all over but it is a gram negative antibiotic with good promise so we'll see. Culd be another TTPH in 2018....

    VTL from 21...

    XBIT....Trading that one. New IPO,,,In at $23 out at $30...Now back in 22's as of Friday for round 2...

    That's it for now...Too profits in QURE mid 33's and will look to get back in 19-21...

    TTPH would love 35's but no way I guess....

    TBPH...Has promise but I got board owning it...

  • golongin2008 golongin2008 Apr 25, 2015 1:21 PM Flag

    AK....Next time you need to tell me a stock is going to double in about two months and I'd bought it regardless...! LOL.... Nice job on ESPR for sure....

    ZSPH.... If both RLYP and ZSPH go according to Hoile and get approved, and the market is as large as the pundits think it could be...

    I firmly believe both companies will be acquired... If simply makes too much sense. Large potential market and an unmet medical need. Only two approved players and drugs to address it in the world. Both one drug companies. 1-3 billion dollar per year in potential sales split between only two companies. Both pretty cash rich right now. If I have ever seen a buyout set up, this one could be it IMHO!! So obviously I want to own both and fairly large too.. You should too if you will let yourself see the forrest through the trees...

  • golongin2008 golongin2008 Apr 25, 2015 11:26 AM Flag

    AK...Fghton is me...GL....Old name that I signed in on by accident!

  • golongin2008 golongin2008 Apr 24, 2015 2:18 PM Flag

    Just bought more ZSPH at $41.18 avg...Building a fairly large position now AK....

    Yes...Every once and awhile the bio Gods descend upon us and remind us that we are certainly
    not invincible, nor gurus, and just mere mortal men who should never equate pure luck with genius!

  • golongin2008 by golongin2008 Apr 24, 2015 12:26 PM Flag

    Very nice run from the low 31's in the recent biotech sell off. Gotten rid of all the resistance going back up
    except we now need to close above $42... That ladies and gentlemen should be the promised land thereafter... The chart right now though is looking very good....

  • Reply to

    Do you

    by stillllondgo Apr 24, 2015 11:43 AM
    golongin2008 golongin2008 Apr 24, 2015 12:05 PM Flag

    Are you on crack or what? Cancer drug?
    Get some help.....You are obviously illiterate and crazy, which is a bad combo....

  • golongin2008 golongin2008 Apr 24, 2015 11:41 AM Flag

    AK....We're getting wacked today in ZSPH?? Any reason that you could be aware of ?

  • golongin2008 golongin2008 Apr 24, 2015 12:54 AM Flag

    AK....You saw what happened to AERI tonight I hope. Let's hope CLDN doesn't pull that...
    I'm out but wishing you good luck on that one!!!!

  • golongin2008 golongin2008 Apr 23, 2015 10:27 PM Flag

    I'm sorry cynicoptimist that you have lost so much money this week ($19.8 to $12 plus) but don't blame it on me, or Jason Napodano, or anyone else but your greedy self. This stock simply got way ahead of itself for where it is today, and a lot of little folks hoping to make a killing piled on, and there you have it...Not saying it may not have a very bright future, but it is way too early to tell. Most folks here are totally clueless on the process that lies ahead to get approval. Just do a couple of patients....throw on some stem cells....and the
    device gets approved and everyone becomes multi millionaires! Good luck to all of you! Had enough fun for tonight. May well be back after they have done at least five patients and gotten verifiable positive results.
    Would rather pay$25 for something that is real than $12 for pie in the sky, but obviously that sentiment is
    in the vast minority on this Board tonight! LOL! Cheers to all longs and best of luck!!***

    ***think you folks may need it frankly...

  • Reply to

    About Patient Enrollment

    by mikerconfer Apr 23, 2015 7:47 PM
    golongin2008 golongin2008 Apr 23, 2015 10:13 PM Flag

    Mike...When you mix a living organism like stem cells with a medical device you come under an entirely different review and process with the FDA than you do with purely a medical device. The use of stem cells under any way, shape or form to be introduced into the body of a human being, is directly regulated by
    the FDA under the more stringent requirements of a "drug" rather than simply a medical device.

  • golongin2008 golongin2008 Apr 23, 2015 9:36 PM Flag


    Jason Napondano, who is a well respected biotech analyst with Zack's, and who brought NVIV to many of our attention, commented on her disappointing "neurological assessment" on April 20th on Twitter...At that time he was expecting perhaps a PR by the company on the assessment....Don't be scared of technology...
    embrace it...Get out of the rocking chair and get on with it man!

  • Reply to

    About Patient Enrollment

    by mikerconfer Apr 23, 2015 7:47 PM
    golongin2008 golongin2008 Apr 23, 2015 9:25 PM Flag

    longnvivuntil50.... Read your post and your question to your friend "Mike". When you mix a medical device with stem cells you're in a whole new ballgame with the FDA. You go from a medical device approval time frame to a "drug" approval time frame...Lengthy and large clinical trials, and 4-6 years to approval, maybe even more if you run into any major issues. IMHO...

  • golongin2008 golongin2008 Apr 23, 2015 9:14 PM Flag

    The "science" behind this medical device is not the issue. It's apparently safe...The question is does it work.

  • golongin2008 golongin2008 Apr 23, 2015 9:12 PM Flag

    First of all wasn't a quotation. Did you see " " next to what I was paraphrasing?
    Next...You're obviously not up to speed here.. The results of Patient 2's recent check-up were
    reported all over Twitter a few days ago.. It was the primary reason the stock went down four days
    ago off it's highs. Read up and get informed.

  • golongin2008 golongin2008 Apr 23, 2015 8:41 PM Flag

    Hey, you copy Wikipedia really well....Nice job. Bet you did that using other people's homework in school too.

    As an FYI...I was a founding shareholder in four medical device companies that went on the NASDAQ, two of which were bought out later, one by JNJ. The bottom line is the physician has the ultimate decision to use or not to use any given device, or drug, whether under an HDE or otherwise. My point was simply that NVIV has been given a free pass on up to five patients under an HDE. Thus far the device appears to be "safe' so that is a positive. With the first two is is doubtful that one could say it works to any degree or not. My only point was that for the next three (3) patients the device needs to be shown to actually produce results.
    Patient 1 was in the category of maybe it did, maybe it didn't. Patient 2 seems to be in the category at this
    time that it did not produce any meaningful results. But she inturn had a more severe spinal cord injury than
    Patient 3???

    My earlier point was simply that might it not be wiser to invest in this company after trial results have shown at least one patient who's injuries responded to the scaffold with unequivocal positive results? And yes...I owned the stock pretty large at $1.40 and sold it just over $3 pre split.

  • golongin2008 golongin2008 Apr 23, 2015 8:23 PM Flag

    HarvardmeatsyourlocaJC.... Almost as dumb as your call for $25 in the next four weeks...Is that the amount you need to save your mortgage? Good luck to you!!

  • golongin2008 golongin2008 Apr 23, 2015 8:07 PM Flag

    To "Mike" the resident guru here....What part do you feel is "ridiculous". Do you not know the regs that are involved here? The company under a HDE gets a very limited number of chances to prove their drug or device works, is safe, and addresses an unmet medical or medical device need for a serious condition or disease. Even one major
    problem can and will put the kabosh to an HDE. Didn't they tell you that when you
    graduated from gas station attendant school? Let's compare experience...
    and knowledge in the areas I wrote of big man....

  • golongin2008 golongin2008 Apr 23, 2015 6:44 PM Flag

    People here need to understand that a physician under a HDE just cannot willy nilly grab anyone who comes into a hospital in an emergency situation and implant an investigational device in their spine. Those types of procedures require the physician and the hospital to comply with specific FDA language, applications, approvals and regulations. If the physician abuses those regulations his license could be in jeopardy.

    One of the criteria that the hospital and physician must represent is that the investigational device being used is likely to provide material benefit to the patient, and that a similar FDA approved device is not available elsewhere. While the second criteria might be applicable to the scaffold, what about the first?

    When the initial scaffold was first implanted in a patient the first criteria was believed to be true.

    But now there seems to be at least one physician with Patient #2 who said he observed no benefit
    whatsoever as the paralysis is basically the same today as it was right after the device was implanted.

    So it may well be more difficult to use the device in further patients if they get similar results to Patient 2.
    As for Patient 1..Was the improvement perceived a result of using the scaffold or simply did the patient
    sustain less severe spinal cord injuries than Patient 2? This could well explain why we haven't seen
    any new implants of the device recently. The company can literally not afford more results like Patient
    2 so maybe they are being very careful in handpicking the next potential patients....IMHO...

2.050.0000(0.00%)Mar 19 4:00 PMEDT